PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CNTF 1,613 Target Target aFGF 899 10 0.01 -0.99 0.01 0.70
CCL19 658 Target Target DC-CK1 22 1 0.01 -0.98 0.05 0.70
bFGF 9,327 Target Target CD34 24,598 126 0.01 -0.99 0.01 0.64
CCL19 658 Target Target CCL8 197 3 0.01 -0.99 0.02 0.71
Complement Component C3c 15 Target Target APOA1 958 1 0.01 -0.97 0.07 0.70
Cox-2 21,583 Target Target EGF 27,487 205 0.01 -0.99 0.01 0.63
BLyS 457 Target Target CD154 1,512 7 0.01 -0.99 0.02 0.70
BMP-4 1,255 Target Target BMPR1A 279 5 0.01 -0.99 0.02 0.70
Calmodulin 25,240 Target Target DAPK2 27 7 0.01 -0.86 0.26 0.65
APOH 110 Target Target APOC1 126 1 0.01 -0.99 0.01 0.74
ALK Phos 19 Target Target CD146 729 1 0.01 -0.97 0.05 0.70
APOA2 118 Target Target CALR 117 1 0.01 -0.99 0.01 0.74
ApoE2 517 Target Target APOA1 958 6 0.01 -0.99 0.01 0.71
Glutathione S-Transferase A1 111 Target Target Multidrug Resistance Protein 1 495 2 0.01 -0.99 0.02 0.71
Eotaxin-3/CCL26 26 Target Target CXCL11 526 1 0.01 -0.98 0.04 0.71
Epigen 27 Target Target Erbb2 4,536 3 0.01 -0.94 0.11 0.67
CD154 1,512 Target Target CD254 9 1 0.01 -0.94 0.11 0.69
Calmodulin 25,240 Target Target BDNF 11,163 144 0.01 -0.99 0.01 0.64
CD4 112,219 Target Target CCL2 3,560 172 0.01 -0.97 0.05 0.61
Myeloperoxidase 16,181 Target Target CXCL2 750 30 0.01 -0.98 0.04 0.65
ANXA7 35 Target Target EPHB2 385 1 0.01 -0.98 0.03 0.71
Proteinase-Activated Receptor 1 133 Target Target Macrophage Metalloelastase 100 1 0.01 -0.99 0.01 0.74
AXL 633 Target Target Alpha Platelet-Derived Growth Factor Receptor 21 1 0.01 -0.98 0.05 0.70
Erbb2 4,536 Target Target AKT3 293 10 0.01 -0.98 0.03 0.68
Steroid 5-Alpha-Reductase 293 Target Target 11-Beta-Hydroxylase 721 4 0.01 -0.99 0.01 0.71
ACAT2 145 Target Target FABP1 90 1 0.01 -0.99 0.01 0.74
FABP1 90 Target Target CXCL3 145 1 0.01 -0.99 0.01 0.74
CXCL3 145 Target Target CCL21 808 3 0.01 -0.99 0.02 0.71
APOH 110 Target Target APOA2 118 1 0.01 -0.99 0.01 0.74
CCL18 256 Target Target Eotaxin 2,457 7 0.01 -0.98 0.03 0.69
AMBP 160 Target Target Kallikrein-6 79 1 0.01 -0.99 0.01 0.73
CCL4 5,638 Target Target CCL21 808 19 0.01 -0.99 0.02 0.67
Urokinase-Type Plasminogen Activator 3,939 Target Target D-Dimer 6,185 44 0.01 -0.99 0.01 0.67
Collagen 138,882 Target Target BMP-4 1,255 118 0.01 -0.95 0.09 0.61
EPHB3 118 Target Target ANGPT2 105 1 0.01 -0.99 0.01 0.74
CXCL2 750 Target Target CCL21 808 7 0.01 -0.99 0.01 0.71
ENO2 87 Target Target EPHA3 140 1 0.01 -0.99 0.01 0.74
C5a 4,164 Target Target Eotaxin 2,457 29 0.01 -0.99 0.01 0.68
CCL7 274 Target Target DNAJB1 44 1 0.01 -0.99 0.02 0.72
CCL18 256 Target Target CXCL2 750 4 0.01 -0.99 0.02 0.71
Endoglin 1,333 Target Target CD254 9 1 0.01 -0.94 0.11 0.69
BMP-6 386 Target Target BMPR1A 279 3 0.01 -0.99 0.01 0.72
APOH 110 Target Target APOA1 958 3 0.01 -0.98 0.03 0.70
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
DC-CK1 22 Target Target CXCL11 526 1 0.01 -0.98 0.05 0.71
AACT 109 Target Target APOE 12,771 11 0.01 -0.95 0.10 0.66
Androgen Receptor 12,918 Target Target Aldo-Keto Reductase Family 1 Member C3 8 3 0.01 -0.79 0.38 0.66
CAMK2D 21 Target Target CYR61 539 1 0.01 -0.97 0.05 0.71
CD1A 2,739 Target Target CCL21 808 14 0.01 -0.99 0.02 0.69
Eotaxin 2,457 Target Target CXCL10/IP-10 114 5 0.01 -0.98 0.04 0.69